CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- UPLOAD Other SEC-generated Letter
- DEFA14A Proxy Proxy Materials
- S-1 Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale
- 424B5 Offering Prospectus
- 4 Open-market buy CFO, Gen Counsel and Secretary bought 10,000 shares at an average $0.34 ($3,369)
- 8-K Event Results of operations
Page 17 of 33 · 643 filings